

Learn about common and serious Levomilnacipran XR (Fetzima) side effects, how to manage them, and when to call your doctor right away.
Every medication comes with potential side effects, and Levomilnacipran XR (brand name Fetzima) is no exception. The good news: most side effects are mild, predictable, and often improve within the first few weeks of treatment. But some are serious enough that you need to know what to watch for.
This guide covers the common and serious side effects of Levomilnacipran XR based on FDA labeling, who may be at higher risk, and practical tips for managing them.
Levomilnacipran XR is an SNRI (serotonin-norepinephrine reuptake inhibitor) approved for major depressive disorder (MDD) in adults. It works by increasing levels of both serotonin and norepinephrine in the brain, with a notably stronger effect on norepinephrine compared to other SNRIs. This unique profile gives it certain benefits — but also shapes its side effect pattern, particularly around heart rate, blood pressure, and urinary symptoms.
These are the side effects that occur most frequently in clinical trials. They're generally mild to moderate and often decrease over time:
These are less common but require immediate medical attention:
Like all antidepressants, Levomilnacipran XR carries an FDA boxed warning about an increased risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) during the first few months of treatment. This doesn't mean the medication causes suicidal thoughts in most people — but it means you should be closely monitored, especially early on.
Call your doctor or 988 (Suicide & Crisis Lifeline) immediately if you experience new or worsening suicidal thoughts, agitation, or unusual changes in behavior.
A potentially life-threatening condition that can occur when too much serotonin builds up in the body. The risk is highest when Levomilnacipran XR is combined with other serotonergic medications. Symptoms include:
Seek emergency care immediately if you experience these symptoms.
Levomilnacipran XR can raise both systolic and diastolic blood pressure due to its norepinephrine activity. Your doctor should check your blood pressure before starting and regularly during treatment. If you already have high blood pressure, it needs to be well controlled before beginning this medication.
SNRIs including Levomilnacipran XR can interfere with platelet function, increasing the risk of bruising and bleeding. This risk is higher if you also take NSAIDs (like ibuprofen), aspirin, or blood thinners.
Levomilnacipran XR can trigger an episode of angle-closure glaucoma in people with anatomically narrow angles. Symptoms include eye pain, vision changes, and swelling or redness around the eye. This requires emergency treatment.
SNRIs can cause dangerously low sodium levels, especially in older adults and people taking diuretics. Symptoms include headache, difficulty concentrating, memory problems, confusion, weakness, and unsteadiness.
Rare but possible. People with a history of seizures should discuss the risks with their doctor before starting Levomilnacipran XR.
Levomilnacipran XR can trigger manic episodes in people with bipolar disorder, which is why screening for bipolar disorder is important before starting any antidepressant.
Stopping Levomilnacipran XR abruptly can cause withdrawal-like symptoms including dizziness, nausea, headache, irritability, and "brain zaps" (electric shock sensations). Never stop taking Levomilnacipran XR without your doctor's guidance. Your doctor will taper your dose gradually.
Elderly patients are at higher risk for hyponatremia (low sodium) and may be more sensitive to the cardiovascular effects like increased heart rate and blood pressure. Doctors should monitor these patients more closely.
Levomilnacipran XR is cleared through the kidneys, so dosing adjustments are needed for patients with renal impairment. The maximum dose is 80 mg/day for moderate kidney problems and 40 mg/day for severe kidney problems.
Levomilnacipran XR should only be used during pregnancy if the potential benefit justifies the potential risk. Babies exposed to SNRIs late in pregnancy may experience complications after delivery. Discuss the risks and benefits carefully with your doctor.
Most common side effects improve within 2-4 weeks. If they persist or become intolerable, your doctor can adjust your dose or discuss alternative medications.
Levomilnacipran XR is generally well-tolerated, and many patients find the side effects manageable — especially as their body adjusts over the first few weeks. The key is knowing what's normal, what's not, and when to call your doctor.
Keep all follow-up appointments, especially in the first few months. Report any new or worsening symptoms promptly. And never stop or change your dose without medical guidance.
If you're currently taking Levomilnacipran XR and need help finding it in stock or saving money on your prescription, Medfinder can help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.